Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs

NCT05226884 is registered in ClinicalTrials.gov with Berkeley Eye Center as lead sponsor.

NCT NCT05226884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05226884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
Lead sponsor
Berkeley Eye Center
Phase
Observational
Overall status
Completed
Start date
November 30, 2021
Completion date
August 6, 2022
Enrollment
310 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pseudophakia